Section Arrow
Quote
AORT.NYSE
- Artivion
Quotes are at least 15-min delayed:2025/10/31 04:50 EDT
Pre Market
Last
 --
-- (--)
Bid
42.31
Ask
72.58
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 45.65
+0.66 (+1.47%)
Day High 
46.19 
Prev. Close
44.99 
1-M High
45.83 
Volume 
357.21K 
Bid
42.31
Ask
72.58
Day Low
44.985 
Open
45.4 
1-M Low
38.95 
Market Cap 
2.12B 
Currency USD 
P/E -- 
%Yield 0.17 
10-SMA 43.38 
20-SMA 42.07 
50-SMA 42.14 
52-W High 45.83 
52-W Low 21.97 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.43/0.77
Enterprise Value
2.48B
Balance Sheet
Book Value Per Share
8.90
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
388.54M
Operating Revenue Per Share
7.20
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.258-0.0282-9.85%-- 
Pre Market 0.2657 +0.0077 +2.98%
PACBPacific Biosciences of California1.94-0.07-3.48%-- 
Pre Market 2.02 +0.08 +4.12%
CODXCo-Diagnostics0.4682-0.0255-5.17%-- 
Pre Market 0.482 +0.0138 +2.95%
DXCMDexCom68.2+0.02+0.03%48.01PE
Pre Market 60.58 -7.62 -11.17%
BSXBoston Scientific Corp100.57+0.27+0.27%58.93PE
Pre Market 99.85 -0.72 -0.72%
Quotes are at least 15-min delayed：2025/10/31 04:50 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.